Award recordCONTRACT

CSL BEHRING L.L.C.

PIID VA25115F1390· VHA· 583-INDIANAPOLIS· 6505 · DRUGS AND BIOLOGICALS· FY2015· $264,965 net obligations· UEI H3WKVE9VBLY3· PA

Description

PRIVIGEN 5, 10, 20 GM MODIFICATION ISSUED TO DEINCREASE FUNDING FOR CLOSE OUT

Base award description: PRIVIGEN 5, 10, 20 GM

First action · last action
2015-04-09 · 2015-11-20
Transactions
3
First transaction's obligation
$136,398
Base + all options value (sum of deltas)
$264,965
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D50358
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$272,795$0Base award · 2015-04-09 · this action $136,398 · running total $136,398Modification P00001 · 2015-06-24 · this action $136,398 · running total $272,795Modification P00002 · 2015-11-20 · this action -$7,830 · running total $264,965
  • Base2015-04-09+$136,398= $136,398
  • Mod P000012015-06-24+$136,398= $272,795
  • Mod P000022015-11-20-$7,830= $264,965
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2015-04-09+$136,398$136,398PRIVIGEN 5, 10, 20 GM
Mod P00001· FUNDING ONLY ACTION2015-06-24+$136,398$272,795PRIVIGEN 5, 10, 20 GM MODIFICATION ISSUED TO INCREASE FUNDING TO MATCH PATIENT CARE NEEDS OF THE FACILITY
Mod P00002· CLOSE OUT2015-11-20−$7,830$264,965PRIVIGEN 5, 10, 20 GM MODIFICATION ISSUED TO DEINCREASE FUNDING FOR CLOSE OUT

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H3WKVE9VBLY3)

AwardOffice · PSC / listingNet obligationsFY
36C24826F0207248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$183,903FY2026
36C24826F0187248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$36,781FY2026
36C25226F0318252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$85,484FY2026
36C24826F0091248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$147,122FY2026
36C24826F0037248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$124,240FY2026
36C24824F0327248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$391,583FY2024

Other recipients under 6505 from 583-INDIANAPOLIS (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25116F0847ACTELION PHARMACEUTICALS US, INC.583-INDIANAPOLIS$4,614FY2016
VA25116F0406ROCHE DIAGNOSTICS CORPORATION583-INDIANAPOLIS$17,601FY2016
VA25116P0414ASD SPECIALTY HEALTHCARE, LLC583-INDIANAPOLIS$35,317FY2016
VA25116F0403MCKESSON PLASMA AND BIOLOGICS LLC583-INDIANAPOLIS$29,088FY2016
VA25116P0392MCKESSON CORPORATION583-INDIANAPOLIS$4,760FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25115F1390_3600_V797D50358_3600 · retrieved 2026-09-26.